Article
PD-L1 and TP-53 mRNA and microRNAs Expression in Liquid Biopsy of NSCLC Patients.
2021-02-05
Abstract excerpt
<h4>Introduction: </h4> The expression of PD-L1 (programed cell death ligand 1) protein on neoplastic cells is a factor qualifying cancer patients for immunotherapy. However, the status of PD-L1 mRNA expression in plasma or serum has not been well studied in cancer patients. TP-53 (Tumor Protein p53) as tumor suppressor affects the expression of many genes, including microRNAs that regulate PD-L1 expression. The p...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fa7c9fab-dba0-5e90-8d84-206f5f7506b5
- DOI
- 10.21203/rs.3.rs-153178/v1
